Bulk Manufacturer of Controlled Substances Application: Rhodes Technologies, 61074 [2019-24545]
Download as PDF
61074
Federal Register / Vol. 84, No. 218 / Tuesday, November 12, 2019 / Notices
projects and programs in the following
technology areas: Multi-function
Materials, Cyber, Big Data Analytics/
Artificial Intelligence/Machine
Learning, Directed Energy Science &
Engineering, Advanced Computing and
Software Engineering, Autonomous and
Unmanned Systems, Sensor Systems,
Gun and Projectile Systems, Digital
Engineering, Human Systems
Integration, Quantum Technologies,
Threat Engineering, Mission
Engineering and Analysis, Integrated
Warfare Systems, Virtualization,
Asymmetric Warfare, Manufacturing,
Lethality, Surface Offensive & Defensive
Engagements, and Launcher
Technology.
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2019–24483 Filed 11–8–19; 8:45 am]
BILLING CODE 4410–11–P
Controlled
substance
Drug
code
Levorphanol ...................
Morphine ........................
Oripavine .......................
Thebaine ........................
Oxymorphone ................
Noroxymorphone ...........
Tapentadol .....................
Fentanyl .........................
9220
9300
9330
9333
9652
9668
9780
9801
Schedule
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for conversion and sale to finished
dosage form manufacturers. In reference
to drug codes 7360 (marihuana), and
7370 (tetrahydrocannabinols), the
company plans to bulk manufacture
these drugs as synthetic cannabidiol
(CBD) and tetrahydrocannabinol (THC).
No other activities for drug codes 7360
and 7370 are authorized for this
registration.
Dated: October 30, 2019.
William T. McDermott,
Assistant Administrator.
DEPARTMENT OF JUSTICE
[FR Doc. 2019–24545 Filed 11–8–19; 8:45 am]
Drug Enforcement Administration
BILLING CODE 4410–09–P
[Docket No. DEA–541]
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Rhodes
Technologies
ACTION:
Drug Enforcement Administration
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 13, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on August 16, 2019,
Rhodes Technologies, 498 Washington
Street, Coventry, Rhode Island 02816
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
DATES:
Controlled
substance
Marihuana ......................
Tetrahydrocannabinols ..
Dihydromorphine ...........
Methylphenidate ............
Codeine .........................
Dihydrocodeine ..............
Oxycodone ....................
Hydromorphone .............
Hydrocodone .................
VerDate Sep<11>2014
Drug
code
7360
7370
9145
1724
9050
9120
9143
9150
9193
17:47 Nov 08, 2019
Schedule
I
I
I
II
II
II
II
II
II
Jkt 250001
Lisdexamfetamine ..
Methylphenidate .....
ANPP (4-Anilino-Nphenethyl-4-piperidine).
Phenylacetone ........
Cocaine ..................
Codeine ..................
Oxycodone .............
Hydromorphone ......
Hydrocodone ..........
Morphine .................
Oripavine ................
Thebaine .................
Opium extracts .......
Opium fluid extract
Opium tincture ........
Opium, powdered ...
Oxymorphone .........
Noroxymorphone ....
Fentanyl ..................
Schedule
1205
1724
8333
II
II
II
8501
9041
9050
9143
9150
9193
9300
9330
9333
9610
9620
9630
9639
9652
9668
9801
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for conversion to other controlled
substances and sale to its customers, for
dosage form development, for clinical
trials, and for use in stability
qualification studies.
Dated: October 30, 2019.
William T. McDermott,
Assistant Administrator.
BILLING CODE 4410–09–P
Bulk Manufacturer of Controlled
Substances Application: Cambrex
Charles City
ACTION:
Drug code
[FR Doc. 2019–24543 Filed 11–8–19; 8:45 am]
[Docket No. DEA–539]
Notice of application.
Controlled
substance
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Notice of application.
[Docket No. DEA–534]
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 13, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 15, 2019, Cambrex
Charles City, 1205 11th Street, Charles
City, Iowa 50616–3466 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Controlled
substance
Drug code
Gamma Hydroxybutyric Acid.
Amphetamine .........
PO 00000
Frm 00070
Fmt 4703
Schedule
2010
I
1100
II
Sfmt 4703
Bulk Manufacturer of Controlled
Substances Application: Cambridge
Isotope Lab
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 13, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.33(a), this is notice that on July 24,
2019 Cambridge Isotope Lab, 50
Frontage Road, Andover, Massachusetts
01810–5413 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
DATES:
E:\FR\FM\12NON1.SGM
12NON1
Agencies
[Federal Register Volume 84, Number 218 (Tuesday, November 12, 2019)]
[Notices]
[Page 61074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24545]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-541]
Bulk Manufacturer of Controlled Substances Application: Rhodes
Technologies
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before January 13, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 16, 2019, Rhodes Technologies, 498 Washington
Street, Coventry, Rhode Island 02816 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Dihydromorphine........................ 9145 I
Methylphenidate........................ 1724 II
Codeine................................ 9050 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Hydrocodone............................ 9193 II
Levorphanol............................ 9220 II
Morphine............................... 9300 II
Oripavine.............................. 9330 II
Thebaine............................... 9333 II
Oxymorphone............................ 9652 II
Noroxymorphone......................... 9668 II
Tapentadol............................. 9780 II
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for conversion and sale to finished dosage form manufacturers.
In reference to drug codes 7360 (marihuana), and 7370
(tetrahydrocannabinols), the company plans to bulk manufacture these
drugs as synthetic cannabidiol (CBD) and tetrahydrocannabinol (THC). No
other activities for drug codes 7360 and 7370 are authorized for this
registration.
Dated: October 30, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-24545 Filed 11-8-19; 8:45 am]
BILLING CODE 4410-09-P